MSB 9.58% $1.18 mesoblast limited

Timeframe for 2015, page-2

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    2015 will have results from diabetes,arthritis in the first half,Japan could be the real mover though with an expected approval for market of GVHD. Also Mesoblast can expediate a lot there other trials through Japans new regulatory fast track process.Mesoblast is on the up and up.Also there will be efficacy results later this year from the teva heart trials.Don't ask me to spell.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
-0.125(9.58%)
Mkt cap ! $1.364B
Open High Low Value Volume
$1.27 $1.30 $1.17 $8.404M 6.779M

Buyers (Bids)

No. Vol. Price($)
9 98159 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.19 14482 9
View Market Depth
Last trade - 10.52am 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.